AI
ETON icon

Atom Investors’s Eton Pharmaceutcials ETON Stock Holding History

Atom Investors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,068
Closed -$161K – 550
2024
Q4 		$161K Buy
+12,068
New +$122K 0.02% 429

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Atom Investors's ETON Position: Q1 2025 in Review

Atom Investors sold out of Eton Pharmaceutcials (ETON) in Q1 2025, closing a stake of 12,068 shares — an estimated $161K sold.

Atom Investors first reported a position in ETON in Q4 2024 and held it in 1 quarter. The position peaked at $161K in Q4 2024. 86 funds tracked by Wall St. Rank hold ETON as of Q1 2025.

  • Atom Investors reported no remaining Eton Pharmaceutcials position as of Q1 2025 after selling out during the quarter.
  • Atom Investors sold 12,068 Eton Pharmaceutcials shares in Q1 2025, an estimated $161K.
  • Atom Investors first reported a position in Eton Pharmaceutcials in Q4 2024 and held it in 1 quarter.
  • Atom Investors's Eton Pharmaceutcials position peaked at $161K in Q4 2024.
  • 86 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2025.

Based on Atom Investors's 13F filing for Q1 2025, filed 15 May 2025.